Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
SOPHiA GENETICS SA (NASDAQ: SOPH)
SOPH Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
16%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-21.50%
SOPH Stock Analysis
SOPH
PE Ratio:
SOPH
PEG Ratio:
Not Available
SOPH
Forward EPS Growth (12 month):
0.00%
SOPH
PS Ratio:
4.2
SOPH
PSG Ratio:
0.2
SOPH
Forward Revenue Growth (12 month):
20.30%
SOPH Articles
No data was found